The 17th World Conference on Tobacco or Health will host a range of satellite sessions, covering topics such as plain packaging, cessation policies, the WHO FCTC briefing, digital therapeutics and 2018 World No Tobacco Day.
Highlights from these sessions include:
Even when advertising is banned, tobacco packaging can be a very powerful means of promoting products, hence the importance of standardised packaging. In this session you can hear the reflections of government officials from Australia, the United Kingdom and the Republic of Ireland, three countries which have either implemented, or are implementing, standardised packaging of tobacco products. They will discuss the legal, policy and operational challenges of the policy, as well as the potential benefits.”
The session is focused on the impact of chronic tobacco smoking on the course of noncommunicable diseases with special attention to obstructive airway diseases: asthma and COPD.
The speakers will present both clinical and economic attitude to the impact of smoking on individual health and quality of life as well as its influence on public health. Several principal parameters: clinical – FEV1, number of exacerbations, HRQoL, drug consumption, disease progression, or economical – total direct and indirect costs, QALY, HLY and several others will be presented and analyzed.
Both the discussion and the presentations will be based on newest data either from speakers own research or from the 2016-2018 reports of WHO, OECD, World bank etc.
Session participants will learn about:
- the pathophysiology and epidemics of the most common NCDs,
- the influence of smoking on the clinical course of NCDs,
- the economic burden of obstructive lung diseases with special focus on the impact of tobacco,
- the role of education and prophylaxis in decreasing tobacco addiction (Lalonde fields, Ottava Charter),
- the international programs to reduce tobacco impact (WHO)
- the current treatment for tobacco related respiratory disease (COPD) and their exacerbations (asthma).
As only 33% of the world’s population is currently covered by a comprehensive tobacco cessation service, much more is needed to scale up tobacco cessation in most cost effective way using latest technologies and mechanisms to achieve population wide reach. In this session, experts will share updated evidence and insights on the status of Article 14 implementation worldwide and in specific regions, and identify strategies, tools and opportunties to maximise population impact of quitting by embedding cessation policies into health systems. The potential impact of novel nicotine products on cessation will also be covered.
Don’t miss the launch of the Information Kit for Delegate to the Conference of the Parties to the WHO FCTC during the satellite session on the 8th of March 2018.
This is a unique opportunity to hear key voices, such as the Head of the Secretariat of the WHO FCTC, a Bureau Member, an representative of an IGO observer and one from an NGO observe, sharing their experience about COP.
There is a growing movement of youth tobacco control advocates who are standing up against tobacco and turning advocacy into policy action. In China, tobacco control advocates have enlisted the support from entertainment and pop culture celebrities as Key Opinion Leaders featured in these campaigns. In the Philippines, young people have played an important part in the advocacy efforts aimed at higher tobacco taxes. In Indonesia, youth advocates have spoken to mayors, local and national policymakers about the urgent need for tobacco control policies to protect young people. What motivated them? What are their perspectives and experiences? What are some challenges they encountered in their respective countries as they engage in tobacco control? WHO China and the Campaign for Tobacco-Free Kids will moderate a dynamic discussion of young key opinion leaders and youth advocates who have been involved in advocacy for policy action and youth tobacco public awareness campaigns.
IDRC and Cancer Research UK have launched an ambitious new Economics of Tobacco Control Research Initiative across Asia, Africa and Latin America. The session, “A Conversation on Inviting New Actors for Effective Collaborations Towards Advancing Tobacco Control Policy” will invite speakers from Chile, Philippines and Kenya to share their experiences on the critical building blocks necessary for collaborations on the economics of tobacco control.
Founder Dr. Satake’s vision of “Creating the Future of Treatment with an Application” was developed at Johns Hopkins, which drove him to invent "CureApp". It is algorithmic system and complicated math to derive from data identified within IoT device and to provide evidence-based personalized clinical guidance to nicotine addiction patients, which indicated therapeutic effect in clinical study.Currently, it is under the first-ever clinical trial of "digital therapeutics" for regulatory approval and reimbursement in Japan and the US.
2018 World No Tobacco Day; an opportunity for strengthening the role of the cardiovascular community in tobacco control2018 World No Tobacco Day; an opportunity for strengthening the role of the cardiovascular community in tobacco control
This year, the WHO World No Tobacco Day will focus on the important link between cardiovascular (CV) disease and tobacco. This special session aims to demonstrate the crucial role the CV community can and should play in tobacco control, by providing engaging examples of tobacco control advocacy in a variety of contexts. Specific tools, such as the WHF Roadmap on Tobacco Control, will be demonstrated. More information: